HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Changes in activity of hepatic xenobiotic-metabolizing enzymes of tiger puffer (Takifugu rubripes) exposed to paralytic shellfish poisoning toxins.

Abstract
Attempts were made to examine the effect of paralytic shellfish poisoning toxins (PSP) on hepatic xenobiotic-metabolizing enzymes (XMEs) of tiger puffer (Takifugu rubripes). Two groups of nontoxic tiger fish were analyzed, and one group was fed with a PSP-containing diet (PSP group), and another with a PSP-free diet (control group). After 60 days of feeding, they were compared to each other mainly in terms of the activity of XMEs. Both groups did not differ from each other significantly in body weight gain, hepatosomatic index, and condition factor Hepatic level of cytochrome P450 was lower in PSP group than control group. NADPH-cytochrome P450 reductase, NADH-cytochrome b5 reductase, and ethoxyresorufin-O-deethylase (EROD) exhibited a reduced activity in PSP group than control group. Statistical analysis found that the activity or concentration of those enzymes correlated with the hepatic level of PSR with r2=0.497-0.611.
AuthorsJ K Jeon, J S Lee, W J Shim, O Aarakawa, T Takatani, S Honda, T Noguchi
JournalJournal of environmental biology (J Environ Biol) Vol. 29 Issue 4 Pg. 599-603 (Jul 2008) ISSN: 0254-8704 [Print] India
PMID19195404 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Marine Toxins
  • Xenobiotics
  • Cytochrome P-450 CYP1A1
  • Cytochrome-B(5) Reductase
  • NADPH-Ferrihemoprotein Reductase
Topics
  • Animals
  • Cytochrome P-450 CYP1A1 (metabolism)
  • Cytochrome-B(5) Reductase (metabolism)
  • Diet (veterinary)
  • Dose-Response Relationship, Drug
  • Liver (drug effects, enzymology)
  • Marine Toxins (toxicity)
  • NADPH-Ferrihemoprotein Reductase (metabolism)
  • Reference Values
  • Shellfish (toxicity)
  • Takifugu (growth & development, metabolism)
  • Time Factors
  • Weight Gain (drug effects)
  • Xenobiotics (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: